Year archive

EMYRIA LIMITED — 2024 filings

All 58 regulatory filings released by EMYRIA LIMITED (EMD) in 2024, sourced directly from the official regulator.

58 Filings

2024 Period

2024 filings (58)

Filing	Released	Lang
Application for quotation of securities - EMD 7 pages 21.3KB Capital/Financing Update	2024-12-11	English
Section 708A(5)(e) Notice 1 page 90.5KB Capital/Financing Update	2024-12-11	English
Emyria Secures $2.525M in Strongly Supported Placement 3 pages 590.6KB Capital/Financing Update	2024-11-26	English
Proposed issue of securities - EMD 5 pages 19.4KB Capital/Financing Update	2024-11-26	English
Trading Halt 2 pages 722.1KB Capital/Financing Update	2024-11-24	English
Investor Update - November 2024 11 pages 4.9MB Investor Presentation	2024-11-24	English
Notification of cessation of securities - EMD 5 pages 16.1KB Share Issue/Capital Change	2024-11-14	English
Results of Annual General Meeting 2 pages 110.7KB Declaration of Voting Results & Voting Rights Announcements	2024-11-11	English
Response to ASX Price Query 4 pages 1.0MB Regulatory Filings	2024-11-11	English
Emyria & UWA Partner to License Novel Serotonin Therapies 4 pages 363.0KB Capital/Financing Update	2024-10-30	English
Proposed issue of securities - EMD 5 pages 18.3KB Share Issue/Capital Change	2024-10-30	English
September 2024 Quarterly Activities Report and Appendix 4C 9 pages 1.6MB Interim / Quarterly Report	2024-10-29	English
Emyria Gains Ethics Endorsement for Psilocybin Program 3 pages 470.5KB Regulatory Filings	2024-10-27	English
Annual Report 76 pages 6.4MB Annual Report	2024-10-10	English
Appendix 4G and Corporate Governance Statement 29 pages 529.8KB Regulatory Filings	2024-10-10	English
Notice of Annual General Meeting/Proxy Form 22 pages 521.5KB AGM Information	2024-10-10	English
Letter to Shareholders - Notice of Annual General Meeting 3 pages 281.0KB AGM Information	2024-10-10	English
Change of Director's Interest Notice x 2 5 pages 282.0KB Director's Dealing	2024-09-22	English
Application for quotation of securities - EMD 7 pages 20.0KB Regulatory Filings	2024-09-19	English
Notification regarding unquoted securities - EMD 6 pages 18.3KB Share Issue/Capital Change	2024-09-19	English
Section 708A(5)(e) Notice 1 page 90.4KB Capital/Financing Update	2024-09-19	English
2024 Annual General Meeting - Key Dates 1 page 152. AGM Information	2024-09-15	English
Hidden Gems Webinar Presentation 29 pages 5.8MB Investor Presentation	2024-09-05	English
Emyria Shares Interim Success in PTSD Treatment Program 7 pages 636.0KB Capital/Financing Update	2024-09-01	English
Appendix 4E & Annual Report for the Year Ended 30 June 2024 71 pages 1.3MB Annual Report	2024-08-29	English
Results of Meeting 2 pages 109.8KB Declaration of Voting Results & Voting Rights Announcements	2024-08-20	English
June 2024 Quarterly Activities Report and Appendix 4C 10 pages 2.9MB Interim / Quarterly Report	2024-07-29	English
Notice of General Meeting/Proxy Form 23 pages 518.1KB Proxy Solicitation & Information Statement	2024-07-18	English
Letter to Shareholders - Notice of General Meeting 3 pages 279.8KB Proxy Solicitation & Information Statement	2024-07-18	English
Ceasing to be a substantial holder 2 pages 403.3KB Major Shareholding Notification	2024-07-14	English
Becoming a substantial holder 3 pages 486.4KB Major Shareholding Notification	2024-07-14	English
Emyria, UWA Secure $499K Grant for MDMA Analogue Program 4 pages 363.2KB Capital/Financing Update	2024-06-30	English
Empax Centre Selected As Key Site In Global PTSD Study 3 pages 470.6KB Regulatory Filings	2024-06-19	English
Management Changes 2 pages 343.9KB Board/Management Information	2024-06-10	English
Change in substantial holding 3 pages 243.0KB Major Shareholding Notification	2024-05-09	English
Application for quotation of securities - EMD 7 pages 21.5KB Capital/Financing Update	2024-05-06	English
Notification regarding unquoted securities - EMD 7 pages 22.0KB Share Issue/Capital Change	2024-05-06	English
Section 708A(5)(e) Notice 1 page 90.5KB Capital/Financing Update	2024-05-06	English
March 2024 Quarterly Activities Report and Appendix 4C 8 pages 598.5KB Interim / Quarterly Report	2024-04-25	English
Emyria Receives Bids of $2.3M to Expand Clinical Services 3 pages 690.3KB Capital/Financing Update	2024-04-22	English
Proposed issue of securities - EMD 9 pages 32.1KB Capital/Financing Update	2024-04-22	English
Trading Halt 2 pages 803.1KB Capital/Financing Update	2024-04-18	English
Emyria Opens Empax Centre to Advance Mental Health Care 5 pages 2.0MB Capital/Financing Update	2024-04-09	English
Emyria Expands Specialist AP Team - First Female for MDMA-AT 4 pages 461.2KB Regulatory Filings	2024-04-04	English
Emyria, Reach Wellness Enter MDMA-AT Research Agreement 5 pages 706.1KB Regulatory Filings	2024-04-02	English
Notification of cessation of securities - EMD 5 pages 16.2KB Regulatory Filings	2024-03-18	English
Response to ASX Aware Query 6 pages 1.1MB Regulatory Filings	2024-03-11	English
Response to ASX Price Query 4 pages 997.7KB Regulatory Filings	2024-03-07	English
Emyria Half Year Results FY2024 3 pages 347.0KB Interim / Quarterly Report	2024-02-28	English
Appendix 4D and Half Year End Financial Report 29 pages 1.4MB Interim / Quarterly Report	2024-02-27	English
Notification of cessation of securities - EMD 5 pages 16.3KB Regulatory Filings	2024-02-22	English
Webinar Presentation 17 pages 4.0MB Investor Presentation	2024-02-01	English
December 2023 Quarterly Activities Report and Appendix 4C 8 pages 1.3MB Interim / Quarterly Report	2024-01-30	English
Notification of cessation of securities - EMD 5 pages 25.9KB Regulatory Filings	2024-01-29	English
Emyria Receives $2.5M R&D Tax Incentive Refund 2 pages 335.4KB Regulatory Filings	2024-01-14	English
Emyria Specialist Granted Authorised Prescriber Status 3 pages 806.4KB Regulatory Filings	2024-01-09	English
Company Overview and Strategic Update 29 pages 6.5MB Investor Presentation	2024-01-09	English
Change of Director's Interest Notice - M. Winlo 3 pages 230.4KB Director's Dealing	2024-01-01	English